Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Overall survival and long-term outcomes from the randomized, double-blind, placebo-controlled, phase III IMerge trial of imetelstat for lower-risk myelodysplastic syndromes.
Journal: Haematologica
Published: June 22, 2026
Association between treatment-emergent cytopenias and clinical responses to imetelstat in lower-risk myelodysplastic syndromes.
Journal: Blood cancer journal
Published: February 03, 2026
Effect of prior therapy on the clinical activity of imetelstat in patients with transfusion-dependent, ESA-relapsed or -refractory/-ineligible LR-MDS.
Journal: Blood cancer journal
Published: September 18, 2025
Clinical outcomes and safety in patients with lower-risk myelodysplastic syndromes treated with imetelstat: Substudy of the phase 3 IMerge trial.
Journal: British journal of haematology
Published: July 29, 2025
Prognostic Impact of Oncogenic Fibroblast Growth Factor Receptor Alterations in Patients With Advanced Solid Tumors in a Real-World Setting.
Journal: Cancer medicine
Published: June 27, 2024
Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: Lancet (London, England)
Published: June 30, 2023
A phase 1 study of intravenous mitazalimab, a CD40 agonistic monoclonal antibody, in patients with advanced solid tumors.
Journal: Investigational new drugs
Published: October 18, 2022
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
Journal: JCO precision oncology
Published: August 11, 2022
Methods and applications of percentile estimation.
Journal: Journal of biopharmaceutical statistics
Published: June 26, 2019
Rejoinder to Chen's letter.
Journal: Journal of biopharmaceutical statistics
Published: February 07, 2017
Last Updated: 09/26/2026